Previous research has reported that NSAIDs only alter Alzheimer disease incidence in ApoE4 carriers, suggesting an interaction between the potential therapeutic mechanism of NSAIDs and the pathological mechanisms of ApoE4. The gene discussed is APOE; the disease is Alzheimer disease.